Anavex submits Nasdaq compliance plan after late filing of quarterly report

• Anavex submitted a compliance plan to Nasdaq on July 20, 2026 to regain timely filing status under Listing Rule 5250(c)(1).
• Nasdaq issued a deficiency notice on May 20, 2026 tied to the late Form 10-Q for the quarter ended March 31, 2026.
• Shares continue trading on the Nasdaq Global Select Market under AVXL while Nasdaq reviews the plan.
• If Nasdaq rejects the plan, Anavex can request a hearing before an independent Hearings Panel.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anavex Life Sciences Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001731122-26-000957), on July 20, 2026, and is solely responsible for the information contained therein.